BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 28623159)

  • 21. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.
    E S; Costa MC; Kurc S; Drożdż A; Cortez-Dias N; Enguita FJ
    Acta Pharmacol Sin; 2018 Jul; 39(7):1085-1099. PubMed ID: 29877319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNA in cardiovascular disease.
    Fung EC; Butt AN; Eastwood J; Swaminathan R; Sodi R
    Adv Clin Chem; 2019; 91():99-122. PubMed ID: 31331491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MicroRNAs: a role in the development of cardiovascular disease, the possibility for clinical application.].
    Velikiy DA; Gichkun OE; Shevchenko AO
    Klin Lab Diagn; 2018; 63(7):403-409. PubMed ID: 30720954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating microRNAs to predict heart failure after acute myocardial infarction in women.
    Lalem T; Devaux Y
    Clin Biochem; 2019 Aug; 70():1-7. PubMed ID: 31132347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs and the heart: small things do matter.
    Papoutsidakis N; Deftereos S; Kaoukis A; Bouras G; Giannopoulos G; Theodorakis A; Angelidis C; Hatzis G; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):216-30. PubMed ID: 23470079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure.
    Cruz MS; da Silva AMG; de Souza KSC; Luchessi AD; Silbiger VN
    Heart Fail Rev; 2020 Mar; 25(2):321-329. PubMed ID: 31254148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
    Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
    Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNAs in cardiovascular disease - clinical application.
    Schulte C; Karakas M; Zeller T
    Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
    Viereck J; Thum T
    Circ Res; 2017 Jan; 120(2):381-399. PubMed ID: 28104771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.
    Halushka PV; Goodwin AJ; Halushka MK
    Annu Rev Pathol; 2019 Jan; 14():211-238. PubMed ID: 30332561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction.
    Liu X; Yuan L; Chen F; Zhang L; Chen X; Yang C; Han Z
    Clin Lab; 2017 Jan; 63(1):101-109. PubMed ID: 28164501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating microRNAs as emerging cardiac biomarkers responsive to acute exercise.
    de Gonzalo-Calvo D; Dávalos A; Fernández-Sanjurjo M; Amado-Rodríguez L; Díaz-Coto S; Tomás-Zapico C; Montero A; García-González Á; Llorente-Cortés V; Heras ME; Boraita Pérez A; Díaz-Martínez ÁE; Úbeda N; Iglesias-Gutiérrez E
    Int J Cardiol; 2018 Aug; 264():130-136. PubMed ID: 29776561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biology of circulating microRNAs in cardiovascular disease.
    Min PK; Chan SY
    Eur J Clin Invest; 2015 Aug; 45(8):860-74. PubMed ID: 26046787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MicroRNA--a new diagnostic tool in coronary artery disease and myocardial infarction].
    Fic P; Kowalczuk K; Grabarska A; Stepulak A
    Postepy Hig Med Dosw (Online); 2014 Apr; 68():410-8. PubMed ID: 24864093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory RNAs and cardiovascular disease - with a special focus on circulating microRNAs.
    Dlouhá D; Hubáček JA
    Physiol Res; 2017 Apr; 66(Suppl 1):S21-S38. PubMed ID: 28379027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct screening of plasma circulating microRNAs.
    Songia P; Chiesa M; Valerio V; Moschetta D; Myasoedova VA; D'Alessandra Y; Poggio P
    RNA Biol; 2018; 15(10):1268-1272. PubMed ID: 30252594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs in cardiovascular disease: an introduction for clinicians.
    Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
    Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNAs: novel biomarkers for cardiovascular diseases.
    Xu J; Zhao J; Evan G; Xiao C; Cheng Y; Xiao J
    J Mol Med (Berl); 2012 Aug; 90(8):865-75. PubMed ID: 22159451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.